M11.071
Hydroxyapatite deposition disease, right ankle and foot
Clinical Classification Guidelines
Medical Intelligence & Overview
Hydroxyapatite deposition disease (HADD) is a condition characterized by the buildup of calcium phosphate crystals, specifically hydroxyapatite, in or around soft tissues such as tendons and bursae. When this calcification occurs in the right ankle and foot, it can cause pain, swelling, and restricted movement. This condition is often associated with inflammation and may mimic other joint or soft tissue issues, making accurate diagnosis important for appropriate management.
Causes & Symptoms
Clinical Causes: Degeneration of tendons or cartilage leading to calcium crystal deposits Repetitive stress or overuse of the affected area Aging processes affecting connective tissues Previous injuries or trauma to the ankle and foot Genetic predisposition to calcification in soft tissues Metabolic imbalances, such as disorders affecting calcium and phosphate levels Inflammatory or degenerative musculoskeletal conditions
Key Symptoms: Localized pain in the right ankle and foot, especially during movement or pressure Swelling and tenderness around the affected tendons or joints Reduced range of motion in the ankle and foot Palpable or visible hard nodules or calcifications in soft tissues Possible warmth and redness if inflammation is significant Sensitivity to touch in the affected area
Diagnostic & Treatment
Diagnosis Path: Diagnosing hydroxyapatite deposition disease involves a combination of clinical assessment and imaging studies. Healthcare providers typically perform a physical examination to identify tenderness and swelling. Imaging techniques such as X-rays can reveal calcified deposits characteristic of HADD. Ultrasound may also be used to visualize soft tissue calcifications more clearly. In some cases, additional tests like MRI can help assess the extent of tissue involvement and exclude other conditions. Laboratory tests are generally not necessary unless an underlying metabolic disorder is suspected.
Treatment Protocols: Management of hydroxyapatite deposition disease focuses on alleviating symptoms and reducing inflammation. Common treatment options include: - Rest and activity modification to prevent aggravation - Nonsteroidal anti-inflammatory drugs (NSAIDs) to reduce pain and inflammation - Physical therapy to maintain joint flexibility and strengthen surrounding muscles - Corticosteroid injections in cases of persistent inflammation - Use of ice packs to decrease swelling and discomfort - In severe or refractory cases, procedures such as ultrasound-guided needling or surgical removal of calcifications may be considered It is important to follow a healthcare provider's guidance for appropriate treatment tailored to the severity and specific circumstances of the condition.
Clinical Advice & FAQs
Billing Guidance
Is M11.071 a billable ICD-10 code?
Yes, M11.071 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M11.071?
Clinical documentation must specify the nature of Hydroxyapatite deposition disease, right ankle and foot and any associated comorbidities for accurate reporting.
Cite this Clinical Reference